# KFF

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/kff-company
Canonical HTML page: https://getbiobrief.com/entity/kff-company

## Recent coverage (1 stories)

### Medicare Part D Subsidy Cut: Drugmakers Face $3.6B Shift in Patient Access
2026-07-29 18:16:37 · Sentiment: Bearish · Impact: 7/10 · Sources: 2

The termination of the $3.6 billion Part D premium subsidy could alter prescription utilization patterns for 25 million Medicare beneficiaries, potentially reducing demand for branded drugs and pressuring pharma companies reliant on Part D volume.
Full story: https://getbiobrief.com/story/medicare-part-d-subsidy-cut-drugmaker-access

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.